Anthony Fauci

Q: What Schools Are Affiliated With Anthony Fauci

Anthony Fauci is affiliated with the following schools: Washington University in St. Louis, College of the Holy Cross, Columbia University, Pennsylvania State University, University of Oxford, Cornell University, Weill Cornell Medicine, University of Pennsylvania, University of Genoa, University of Toronto, Georgetown University, George Washington University, McGill University

Anthony Fauci's AcademicInfluence.com Rankings

Anthony Fauci

Biology

#101

World Rank

#185

Historical Rank

#57

USA Rank

Immunology

World Rank

Historical Rank

USA Rank

biology Degrees

Download Badge

Biology

Anthony Fauci's Degrees

Doctorate Medicine Cornell University

Why Is Anthony Fauci Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anthony Stephen Fauci is an American physician-scientist and immunologist who served as the director of the National Institute of Allergy and Infectious Diseases from 1984 to 2022, and the chief medical advisor to the president from 2021 to 2022.

(See a Problem?)

Anthony Fauci's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 (1998) (3678)
Wegener granulomatosis: an analysis of 158 patients. (1992) (2702)
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. (2010) (2232)
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). (2010) (1997)
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. (2010) (1952)
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. (1983) (1920)
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. (2010) (1862)
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. (1997) (1841)
The challenge of emerging and re-emerging infectious diseases (2004) (1736)
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. (1986) (1706)
Coronavirus Infections-More Than Just the Common Cold. (2020) (1681)
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth (1986) (1681)
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease (1993) (1606)
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. (1983) (1580)
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. (1988) (1466)
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. (2008) (1446)
Covid-19 — Navigating the Uncharted (2020) (1412)
Helicobacter pylori in peptic ulcer disease. (1994) (1317)
The immunopathogenesis of human immunodeficiency virus infection. (1993) (1044)
Zika Virus in the Americas--Yet Another Arbovirus Threat. (2016) (945)
Glucocorticosteroid therapy: mechanisms of action and clinical considerations. (1976) (926)
Host factors and the pathogenesis of HIV-induced disease (1996) (914)
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. (1987) (909)
Corticosteroid‐Mediated Immunoregulation in Man (1982) (877)
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. (1998) (841)
Multifactorial nature of human immunodeficiency virus disease: implications for therapy. (1993) (822)
Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes (1988) (819)
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals (2008) (798)
The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. (2010) (796)
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. (1999) (788)
Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations (1984) (786)
Ending the HIV Epidemic: A Plan for the United States. (2019) (767)
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. (1982) (729)
WEGENER'S GRANULOMATOSIS: STUDIES IN EIGHTEEN PATIENTS AND A REVIEW OF THE LITERATURE (1973) (726)
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. (1986) (708)
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. (1989) (698)
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. (1985) (698)
Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV (1994) (680)
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. (1989) (677)
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. (1989) (662)
B cells in HIV infection and disease (2009) (651)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. (2010) (621)
The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. (1974) (572)
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. (1986) (570)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. (2010) (569)
Takayasu Arteritis (1994) (566)
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. (1989) (547)
Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. (2005) (541)
Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. (1989) (527)
Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms (1990) (526)
Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis (1996) (525)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. (2008) (523)
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. (1996) (519)
CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status (2004) (501)
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV* (2002) (500)
Sjögren's syndrome (Sicca syndrome): current issues. (1980) (499)
The immunopathogenesis of HIV infection. (1989) (494)
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages (1990) (491)
Lymphoid organs function as major reservoirs for human immunodeficiency virus. (1991) (489)
The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands (2008) (473)
The 1918 influenza pandemic: insights for the 21st century. (2007) (470)
Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk (1997) (465)
Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. (1994) (465)
Emerging Infectious Diseases: Threats to Human Health and Global Stability (2013) (461)
Toward an Understanding of the Correlates of Protective Immunity to HIV Infection (1996) (453)
Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. (1990) (445)
The perpetual challenge of infectious diseases. (2012) (430)
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. (1990) (424)
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy (1999) (420)
Immunopathogenic Mechanisms of HIV Infection (1996) (413)
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy (2000) (411)
A strategic approach to COVID-19 vaccine R&D (2020) (411)
Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. (1995) (404)
HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. (2019) (398)
Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus (1986) (398)
Mechanisms of glucocorticoid action on immune processes. (1979) (398)
Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates (2003) (394)
AIDS: Re-emergence of HIV after stopping therapy (1999) (389)
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor (1997) (384)
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. (1983) (384)
Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. (1996) (384)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection (2015) (380)
The persistent legacy of the 1918 influenza virus. (2009) (377)
Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines (1998) (377)
HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells (2008) (373)
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. (2016) (369)
Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. (1994) (368)
Infectious diseases: considerations for the 21st century. (2001) (365)
Pathogenic mechanisms of HIV disease. (2011) (359)
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. (1997) (355)
Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. (1986) (355)
Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. (1989) (351)
Surgical Pathology of the Lung in Wegener's Granulomatosis: Review of 87 Open Lung Biopsies From 67 Patients (1991) (346)
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. (2016) (344)
Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow. (1975) (342)
Latent reservoirs of HIV: obstacles to the eradication of virus. (1999) (341)
New concepts in the immunopathogenesis of HIV infection. (1995) (334)
Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. (1991) (331)
Global Vaccine Action Plan 2011-2020. (2013) (327)
Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. (1988) (327)
HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals (2001) (326)
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. (1988) (326)
Takayasu's arteritis and its therapy. (1985) (326)
Emerging Pandemic Diseases: How We Got to COVID-19 (2020) (325)
Interpretation of Head and Neck Biopsies in Wegener's Granulomatosis: A Pathologic Study of 126 Biopsies in 70 Patients (1990) (323)
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. (1984) (319)
Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. (2013) (315)
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. (1988) (315)
Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. (1991) (308)
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. (1997) (303)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention (2011) (303)
A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases (2018) (301)
Ophthalmic involvement in acquired immunodeficiency syndrome. (1984) (298)
What is a pandemic? (2009) (295)
Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. (1990) (294)
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. (1979) (294)
Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. (1975) (292)
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. (1993) (291)
Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. (1988) (290)
An HIV vaccine--evolving concepts. (2007) (287)
The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. (1977) (283)
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. (1996) (283)
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection (1997) (283)
Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. (1996) (281)
The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1 (2009) (279)
Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. (1974) (276)
Universal voluntary testing and treatment for prevention of HIV transmission. (2009) (275)
Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. (1990) (274)
Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. (1998) (274)
HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. (2005) (274)
The AIDS epidemic--considerations for the 21st century. (1999) (273)
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. (1984) (272)
Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. (1983) (268)
Antimicrobial Resistance. (2016) (268)
Isolated angiitis of the central nervous system. Prospective diagnostic and therapeutic experience. (1983) (266)
Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. (1981) (262)
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. (1995) (261)
A new immunodeficiency disorder in humans involving NK cells (1980) (260)
Immunologic abnormalities in the acquired immunodeficiency syndrome. (1986) (258)
Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. (1997) (258)
HIV and AIDS: 20 years of science (2003) (253)
Therapy of the hypereosinophilic syndrome. (1978) (252)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. (2010) (250)
HIV Vaccine Research: The Way Forward (2008) (250)
Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections. (1991) (250)
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection (1997) (249)
Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy (2016) (249)
Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus (1986) (247)
The effect of cytokines and pharmacologic agents on chronic HIV infection. (1992) (247)
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. (2010) (246)
Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. (1986) (245)
B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. (2010) (242)
The Acquired Immunodeficiency Syndrome: An Update (1985) (241)
Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily (2004) (240)
Wegener granulomatosis in children and adolescents: clinical presentation and outcome. (1993) (240)
AIDS--an immunologic reevaluation. (1984) (239)
Wegener's granulomatosis. (1974) (238)
Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals (1999) (237)
SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities. (2021) (237)
Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. (1998) (236)
Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases (2005) (234)
Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. (1998) (234)
Emerging infections: a perpetual challenge (2008) (233)
Host factors in the pathogenesis of HIV disease (1997) (233)
Effect of tumor necrosis factor alpha on mitogen-activated human B cells (1987) (230)
The effect of Hydrocortisone on the kinetics of normal human lymphocytes. (1975) (225)
ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA (1988) (225)
Early antibody therapy can induce long-lasting immunity to SHIV (2017) (224)
Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus (1987) (224)
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. (2015) (223)
HARRISON'S PRINCIPLES OF INTERNAL MEDICINE, 13TH EDITION: (2004) (223)
Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function (1985) (223)
B Cells of HIV-1–Infected Patients Bind Virions through Cd21–Complement Interactions and Transmit Infectious Virus to Activated T Cells (2000) (223)
Race against time (2005) (223)
The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. (1992) (223)
Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. (1997) (221)
Immunopathogenesis of the Acquired Immunodeficiency Syndrome (1985) (221)
Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: Correlation with increased IL-7 (2006) (217)
Building a tuberculosis-free world: The Lancet Commission on tuberculosis (2019) (214)
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. (2002) (214)
Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection. (1990) (202)
Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. (1994) (201)
Influenza vaccines for the future. (2010) (199)
Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. (2007) (199)
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells (2007) (196)
Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals (2007) (195)
Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. (1987) (194)
Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. (1998) (193)
Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. (1995) (192)
Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. (1996) (191)
Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. (1990) (191)
Immunopathogenesis of HIV infection. (1996) (191)
HIV reservoirs as obstacles and opportunities for an HIV cure (2015) (189)
Ebola--underscoring the global disparities in health care resources. (2014) (188)
Compromised B cell responses to influenza vaccination in HIV-infected individuals. (2005) (188)
EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO (1985) (188)
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection (2006) (188)
Pulmonary involvement in the collagen vascular diseases. (1979) (187)
Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. (1987) (186)
Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine. (2018) (185)
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. (2014) (185)
Role of Lymphoid Organs in the Pathogenesis of Human Immunodeficiency Virus (HIV) Infection (1994) (184)
Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. (2003) (184)
CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. (1992) (181)
Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation. (1982) (181)
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy (2016) (180)
ERYTHEMA ELEVATUM DIUTINUM: SKIN AND SYSTEMIC MANIFESTATIONS, IMMUNOLOGIC STUDIES, AND SUCCESSFUL TREATMENT WITH DAPSONE (1977) (180)
Chediak-Higashi gene in humans. I. Impairment of natural - killer function (1980) (180)
Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. (1989) (180)
Bioterrorism—a clear and present danger (2001) (180)
Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals (2003) (180)
Dengue and hemorrhagic fever: a potential threat to public health in the United States. (2008) (179)
Suppression of human B lymphocyte function by cyclophosphamide. (1982) (178)
NK cells in HIV infection: paradigm for protection or targets for ambush (2005) (177)
HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication (2002) (177)
Immune correlates of vaccine protection against HIV-1 acquisition (2015) (175)
Thirty Years of HIV and AIDS: Future Challenges and Opportunities (2011) (174)
Human Cyclic Neutropenia: Clinical Review and Long-Term Follow-up of Patients (1981) (173)
Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients. (1981) (173)
Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor (1983) (172)
Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis. (1971) (169)
Alteration of T-cell functions by infection with HTLV-I or HTLV-II. (1984) (169)
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. (1995) (168)
Enhanced: The Need for a Global HIV Vaccine Enterprise (2003) (168)
Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. (1988) (168)
Impairment of neutrophil bactericidal capacity in patients with AIDS. (1988) (168)
Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes (1976) (167)
Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. (1985) (167)
Factitious fever and self-induced infection: a report of 32 cases and review of the literature. (1979) (166)
Alternate-day prednisone therapy and human lymphocyte subpopulations. (1975) (165)
Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage (1991) (163)
Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein. (1987) (162)
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure (2012) (162)
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine (2010) (161)
Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. (1983) (161)
Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. (1986) (160)
Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy. (2011) (159)
NK cells in HIV infection: Paradigm for protection or targets for ambush (2005) (159)
Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. (1997) (158)
Pandemic Influenza Threat and Preparedness (2006) (158)
Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study (1990) (157)
Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. (1976) (156)
Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. (1987) (156)
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals (1989) (155)
Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. (2008) (155)
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. (1982) (154)
Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells (1992) (154)
Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. (1994) (153)
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. (1987) (153)
Development of effective vaccines against pandemic influenza. (2006) (153)
Dermatologic manifestations of the hypereosinophilic syndrome. (1978) (153)
The management of subglottic stenosis in patients with wegener's granulomatosis (1992) (153)
CD8+ T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages (1996) (152)
HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. (1995) (150)
Lymphotoxin is an important T cell-derived growth factor for human B cells. (1987) (149)
CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. (2007) (149)
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study (2015) (149)
Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. (1987) (148)
cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell interactions (1991) (147)
Cytokine modulation of HIV expression. (1993) (146)
Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. (2008) (145)
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: Implications for antiviral therapy (1998) (145)
Insights into B cells and HIV‐specific B‐cell responses in HIV‐infected individuals (2013) (145)
Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV Infection (1986) (144)
Activation of human B lymphocytes XVI. Cellular requirements, interactions, and immunoregulation of pokeweed mitogen-induced total-immunoglobulin producing plaque-forming cells in peripheral blood. (1980) (144)
Polyangiitis overlap syndrome. Classification and prospective clinical experience. (1986) (144)
Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. (1996) (143)
Immunologic abnormalities in the acquired immunodeficiency syndrome. (1985) (142)
HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. (1996) (141)
Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF). (1982) (139)
The Pathway to a Universal Influenza Vaccine. (2017) (138)
An HIV vaccine--challenges and prospects. (2008) (138)
The effects of interleukin 1 on human B cell activation and proliferation. (1983) (137)
SARS-CoV-2 Viral Variants-Tackling a Moving Target. (2021) (137)
Immunopathogenic mechanisms of HIV infection. (1996) (134)
Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. (1991) (132)
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. (1993) (131)
Serologic and immunologic studies in patients with AIDS in North America and Africa (1987) (131)
Harrisons principles of internal medicine - 15th edition (2001) (130)
Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. (1990) (130)
Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. (1985) (130)
The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7 +/CD4+ T cells As Key Targets in Mucosal Transmission (2011) (130)
Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. (2011) (130)
IMMUNOFLUORESCENT STUDIES IN ADULT CELIAC DISEASE. (1965) (129)
Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. (1978) (125)
Both a precursor and a mature population of dendritic cells can bind HIV. However, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells. (1995) (125)
Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma. (1989) (125)
A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes (1991) (124)
Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. (1991) (124)
Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation. (1985) (124)
Immunoglobulin replacement therapy by slow subcutaneous infusion. (1980) (124)
Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. (1988) (124)
Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. (2001) (123)
Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. (1989) (123)
Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis (2000) (122)
Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. (1990) (122)
Activation of human B lymphocytes. II. Cellular interactions in the PFC response of human tonsillar and peripheral blood B lymphocytes to polyclonal activation by pokeweed mitogen. (1976) (122)
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. (2007) (121)
Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research. (2008) (121)
Vitamin and trace Mineral Deficiency and Excess (2008) (121)
B cell lines as models for inherited phagocytic diseases: abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome. (1984) (120)
The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation (1996) (120)
Immunopathogenesis of HIV infection (1991) (119)
B‐cell responses to HIV infection (2017) (119)
Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. (2000) (118)
HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV (2011) (118)
Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals. (2014) (118)
Emerging and Re-Emerging Infectious Diseases: Influenza as a Prototype of the Host-Pathogen Balancing Act (2006) (117)
In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements (1981) (117)
CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. (1990) (117)
The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage. (1984) (116)
The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. (1990) (116)
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection (2014) (116)
Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. (1997) (115)
The syndrome of Kaposi's sarcoma and opportunistic infections: an epidemiologically restricted disorder of immunoregulation. (1982) (114)
Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function (2003) (114)
Cyclophosphamide-induced remissions in advanced polyarteritis nodosa. (1978) (113)
The Role of CD4+ T Cell Help and CD40 Ligand in the In Vitro Expansion of HIV-1-Specific Memory Cytotoxic CD8+ T Cell Responses (2000) (113)
The next influenza pandemic: can it be predicted? (2007) (113)
The in vitro regulation of human thyrocyte HLA-DR antigen expression. (1985) (113)
Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission (1991) (111)
Lysis of Endogenously Infected CD4+ T Cell Blasts by rIL-2 Activated Autologous Natural Killer Cells from HIV-Infected Viremic Individuals (2008) (111)
Yellow Fever - Once Again on the Radar Screen in the Americas. (2017) (111)
Emerging and Reemerging Infectious Diseases: The Perpetual Challenge (2005) (110)
Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome. (1988) (110)
A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells (1994) (109)
Human B lymphoma cell line producing B cell growth factor. (1985) (108)
Mechanisms of the immunosuppressive and anti-inflammatory effects of glucocorticosteroids. (1978) (108)
Emerging Viral Diseases: Confronting Threats with New Technologies (2014) (108)
Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. (1999) (108)
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. (1987) (106)
Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation. (1977) (106)
Measles in 2019 - Going Backward. (2019) (106)
Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. (1979) (106)
CCR5 Signal Transduction in Macrophages by Human Immunodeficiency Virus and Simian Immunodeficiency Virus Envelopes (2000) (106)
Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. (1998) (105)
A potential role for adrenocorticotropin in regulating human B lymphocyte functions. (1985) (105)
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. (2007) (105)
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States (2015) (104)
The challenge of emerging and re-emerging infectious diseases (2010) (104)
Chikungunya at the door--déjà vu all over again? (2014) (103)
Defective HIV-1 proviruses produce viral proteins (2020) (102)
Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome. (1981) (102)
Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. (1985) (102)
Induction of expression of HIV in latently or chronically infected cells. (1989) (102)
Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera. (1999) (102)
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. (1988) (102)
Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease. (1991) (101)
High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. (1983) (101)
Differential expression of cell activation markers after stimulation of resting human B lymphocytes. (1984) (101)
Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals (2003) (100)
Therapy for Early COVID-19: A Critical Need. (2020) (100)
Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. (2002) (99)
Monoclonal Antibodies for Emerging Infectious Diseases - Borrowing from History. (2018) (99)
Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products. (1984) (98)
Death in the AIDS patient: role of cytomegalovirus. (1983) (98)
Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells. (1987) (98)
Immunopathogenesis of the acquired immunodeficiency syndrome. (1986) (98)
Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern United States. (1982) (97)
Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy. (2012) (97)
Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1 (1991) (96)
Cutaneous pathology in Wegener's granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. (1995) (96)
A histamine-releasing factor from activated human mononuclear cells. (1985) (96)
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection (2017) (96)
Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic Cells (2007) (96)
Further studies of the role of transforming growth factor-beta in human B cell function. (1989) (96)
Experience with surgical treatment of Takayasu's disease. (1991) (95)
Immunomodulators in Clinical Medicine (1987) (95)
Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. (1989) (95)
Effects of in vivo prednisone on in vitro eosinophil and neutrophil adherence and chemotaxis. (1979) (95)
Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. (1992) (94)
IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. (1991) (92)
Ending the HIV/AIDS Pandemic (2018) (92)
Polyclonal activation of bone-marrow-derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay. (1976) (91)
Effect of Immune Activation on the Dynamics of Human Immunodeficiency Virus Replication and on the Distribution of Viral Quasispecies (1998) (91)
Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals. (1975) (91)
Selective suppression of an early step in human B cell activation by cyclosporin A (1983) (90)
Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters. (2003) (90)
Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. (1976) (90)
IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. (1995) (90)
Developmental therapeutics and the acquired immunodeficiency syndrome. (1987) (90)
Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. (1994) (89)
Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. (1985) (89)
T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations. (1982) (89)
Ending AIDS--is an HIV vaccine necessary? (2014) (89)
Seasonal and pandemic influenza preparedness: science and countermeasures. (2006) (88)
Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. (1997) (88)
The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection. (1992) (88)
Development of a human T-T cell hybridoma secreting B cell growth factor. (1983) (88)
Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. (1989) (87)
Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse (2014) (87)
Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome. (1978) (87)
Cross-linking of CD30 induces HIV expression in chronically infected T cells. (1995) (87)
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. (1985) (87)
Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells. (1992) (86)
CD4+ T-lymphocytopenia without HIV infection--no lights, no camera, just facts. (1993) (86)
A simple method for the determination of complement receptor-bearing mononuclear cells. (1976) (86)
Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms (2006) (86)
Comprar Harrison's Principles of Internal Medicine. 18th Ed. 2 Volúmenes | Dennis Kasper | 9780071748896 | Mcgraw-Hill Education (2011) (86)
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. (2002) (85)
Ear disease in patients with wegener's granulomatosis (1982) (84)
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication (2010) (84)
A Way Forward: The National HIV/AIDS Strategy and Reducing HIV Incidence in the United States (2010) (84)
Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)–infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I–uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1 (1998) (84)
USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. (1999) (83)
Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. (2004) (83)
Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. (1988) (83)
Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression. (1995) (82)
Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV. (1998) (82)
Paucity of HIV DNA Methylation in Latently Infected, Resting CD4+ T Cells from Infected Individuals Receiving Antiretroviral Therapy (2012) (82)
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor (2012) (82)
Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. (1983) (82)
Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins. (1994) (81)
The perpetual challenge of antimicrobial resistance. (2014) (81)
Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. (1984) (81)
Toward an AIDS-free generation. (2012) (80)
Tickborne Diseases - Confronting a Growing Threat. (2018) (80)
Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma. (1988) (80)
Unusual radiographic features of Wegener's granulomatosis. (1978) (80)
Role of complement in host defense against experimental disseminated candidiasis. (1978) (80)
Alternate-day corticosteroid therapy. (1978) (80)
Emerging Infectious Diseases in 2012: 20 Years after the Institute of Medicine Report (2012) (80)
Innate Immune Dysfunction in HIV Infection: Effect of HIV Envelope-NK Cell Interactions12 (2006) (79)
Smallpox vaccination policy--the need for dialogue. (2002) (79)
Immunoregulation in autoimmunity. (1980) (79)
Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies. (2001) (79)
IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. (2012) (79)
The role of lymphoid organs in the pathogenesis of HIV infection. (1993) (79)
Ending the HIV-AIDS Pandemic--Follow the Science. (2015) (79)
Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell clone (78)
Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. (1981) (78)
Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice. (1979) (78)
Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle (1987) (78)
Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunity. (1975) (78)
Asthma in the inner city: the perspective of the National Institute of Allergy and Infectious Diseases. (2010) (77)
HIV-1 gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression (2013) (77)
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes (2001) (77)
Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor (1985) (77)
Renal biopsy pathology in Wegener's granulomatosis. (1974) (77)
B-cell exhaustion in HIV infection: the role of immune activation (2014) (76)
Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. (2002) (76)
Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes (2018) (76)
Cutaneous Pathology in Wegener's Granulomatosis (1995) (75)
Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. (2012) (75)
Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation. (1981) (75)
Decreased nucleotide and serotonin storage associated with defective function in Chediak-Higashi syndrome cattle and human platelets. (1976) (74)
Antigen-specific human T-cell clones: development of clones requiring HLA-DR-compatible presenting cells for stimulation in presence of antigen. (1981) (74)
Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir (2014) (74)
Dengue research opportunities in the Americas. (2012) (74)
Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells (1990) (74)
Letter: Pulmonary aspergillosis, inhalation of contaminated marijuana smoke, chronic granulomatous disease. (1975) (74)
Comorbidities in Persons With HIV: The Lingering Challenge. (2019) (73)
Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases. (2018) (73)
Immune Activation with HIV Vaccines (2014) (73)
Apoptosis in HIV infection (1995) (73)
Current therapy in allergy, immunology, and rheumatology (1988) (73)
Radiation therapy of midline granuloma. (1976) (72)
HIV-1 Vaccines and Adaptive Trial Designs (2011) (71)
Intradermal influenza vaccination--can less be more? (2004) (71)
Transmission of multidrug-resistant human immunodeficiency virus--the wake-up call. (1998) (71)
CD40-Mediated Induction of CD4 and CXCR4 on B Lymphocytes Correlates with Restricted Susceptibility to Human Immunodeficiency Virus Type 1 Infection: Potential Role of B Lymphocytes as a Viral Reservoir (1999) (71)
Novel vaccine technologies for the 21st century (2019) (71)
Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. (2006) (69)
Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. (2005) (69)
Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects. (1997) (69)
R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells. (2006) (68)
Differential effect of monoclonal anti-DR antibody on monocytes in antigen- and mitogen-stimulated responses: mechanism of inhibition and relationship to interleukin 1 secretion. (1983) (68)
Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. (2004) (68)
Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic, and immunologic features. (1987) (67)
Heat shock induction of HIV production from chronically infected promonocytic and T cell lines. (1990) (67)
Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. (1987) (66)
The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammator (1998) (66)
Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual (1982) (65)
CXCR4 and CCR5 Genetic Polymorphisms in Long-Term Nonprogressive Human Immunodeficiency Virus Infection: Lack of Association with Mutations other than CCR5-Δ32 (1998) (65)
Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells (1991) (65)
The need for a global HIV vaccine enterprise. Policy forum. (2003) (65)
Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig. (1984) (65)
Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms. (1999) (64)
Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. (1990) (64)
Universal Coronavirus Vaccines - An Urgent Need. (2021) (63)
Efficacy of intermittent colchicine therapy in familial Mediterranean fever. (1977) (63)
The relationship between antibody affinity and the efficiency of complement fixation. (1970) (63)
In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. (1990) (62)
Pandemic influenza viruses--hoping for the road not taken. (2013) (62)
Targeting alpha(4)beta(7) integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection (62)
Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. (1991) (61)
An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic. (2017) (61)
Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations. (1980) (61)
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. (1984) (60)
Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigens. (1984) (60)
Association between Takayasu's arteritis and a B-cell alloantigen in North Americans. (1982) (60)
Idiopathic midline destructive disease (IMDD): a subgroup of patients with the "midline granuloma" syndrome. (1982) (60)
H7N9 Avian Influenza A Virus and the Perpetual Challenge of Potential Human Pandemicity (2013) (60)
Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus. (1982) (60)
A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection. (2004) (59)
Pandemic influenza's 500th anniversary. (2010) (59)
Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion. (1979) (59)
An improved technique for the negative selection of large numbers of human lymphocytes and monocytes by counterflow centrifugation--elutriation. (1980) (59)
Interleukin 1 Induces HIV-1 Expression in Chronically Infected U1 Cells: Blockade by Interleukin 1 Receptor Antagonist and Tumor Necrosis Factor Binding Protein Type 1 (1995) (59)
Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding. (1988) (59)
CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages. (1996) (59)
Considerations for Developing a Zika Virus Vaccine. (2016) (59)
B cell growth factor and T cell growth factor produced by mitogen-stimulated normal human peripheral blood T lymphocytes are distinct molecules. (1982) (59)
Effect of antiretroviral therapy on HIV reservoirs in elite controllers. (2013) (58)
The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis. (1986) (57)
Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations. (1975) (57)
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals (2007) (57)
The Bb fragment of complement factor B acts as a B cell growth factor (1988) (57)
Mechanisms of corticosteroid action on lymphocyte subpopulations. VI. Lack of correlation between glucocorticosteroid receptors and the differential effects of glucocorticosteroids on T-cell subpopulations. (1980) (57)
Immunological reactivity of the lung. I. A guinea pig model for the study of pulmonary mononuclear cell subpopulations. (1976) (57)
Productive HIV infection of resting CD4+ T cells: role of lymphoid tissue microenvironment and effect of immunomodulating agents. (2003) (57)
Immunohistochemical characterization of intrathyroid lymphocytes in Graves' disease. Interstitial and intraepithelial populations. (1984) (57)
New and reemerging diseases: the importance of biomedical research. (1998) (57)
Bioterrorism on the home front: a new challenge for American medicine. (2001) (56)
Complement subcomponent C1q stimulates Ig production by human B lymphocytes. (1991) (56)
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. (1997) (56)
Characterization of Plasmablasts in the Blood of HIV-Infected Viremic Individuals: Evidence for Nonspecific Immune Activation (2013) (56)
The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance. (2008) (56)
Direct effects of a monoclonal B cell differentiation factor and of purified interleukin 1 on B cell differentiation. (1984) (56)
Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle. (1984) (55)
Four Decades of HIV/AIDS - Much Accomplished, Much to Do. (2020) (55)
Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis. (1982) (54)
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation (2006) (54)
Delineation of optimal conditions for producing mouse-human heterohybridomas from human peripheral blood B cells of immunized subjects. (1983) (54)
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn (2021) (54)
Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cells. (1972) (54)
Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. (1989) (54)
Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation. (1996) (53)
Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome. (1985) (53)
Production of B cell growth factor by normal human B cells. (1986) (53)
Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis. (1978) (53)
Twenty-Five Years of HIV/AIDS (2006) (53)
Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy (2003) (53)
Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. (1994) (52)
The story behind COVID-19 vaccines (2021) (52)
Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? (1994) (52)
25 years of HIV (2008) (52)
Wegener's granulomatosis and related diseases. (1977) (52)
Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions. (2020) (52)
Transforming Growth Factor‐β Is a Potent Negative Regulator of Human Lymphocytes (1991) (51)
MALIGNANCIES IN THE AIDS PATIENT: NATURAL HISTORY, TREATMENT STRATEGIES, AND PRELIMINARY RESULTS (1984) (51)
Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation. (1980) (51)
Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1 (1997) (51)
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells (2009) (51)
HIV Envelope Induces Virus Expression from Resting CD4+ T Cells Isolated from HIV-Infected Individuals in the Absence of Markers of Cellular Activation or Apoptosis1 (2003) (51)
Immunologic reactivity of the lung. III. Effects of corticosteroids on alveolar macrophage cytotoxic effector cell function. (1977) (51)
Use of interleukin-2 in patients with acquired immunodeficiency syndrome. (1984) (51)
Biochemical and Biological Characterization of a Dodecameric CD4-Ig Fusion Protein (2002) (50)
Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants (1993) (50)
Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture (1981) (50)
Direct effect of interleukin 2 on the differentiation of human B cells which have not been preactivated in vitro (1985) (50)
HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells. (2006) (50)
Activation of human B lymphocytes. VIII. Differential radiosensitivity of subpopulations of lymphoid cells involved in the polyclonally-induced PFC responses of peripheral blood B lymphocytes. (1978) (50)
Activation and regulation of human immune responses: implications in normal and disease states. (1983) (50)
HIV vaccine development--improving on natural immunity. (2011) (50)
Chronic granulomatous disease. Diagnosis in a 27-year-old man with Mycobacterium fortuitum. (1975) (50)
Opioids and Infectious Diseases: A Converging Public Health Crisis. (2019) (50)
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis. (1993) (49)
Mechanisms of corticosteroid action on lymphocyte subpopulations. III. Differential effects of dexamethasone administration on subpopulations of effector cells mediating cellular cytotoxicity in man. (1978) (49)
Thymic microenvironment induces HIV expression. Physiologic secretion of IL-6 by thymic epithelial cells up-regulates virus expression in chronically infected cells. (1991) (49)
Correction of human cyclic neutropenia with prednisolone. (1978) (49)
Peripheral neuropathy in hypereosinophilic syndrome (1985) (49)
Eastern Equine Encephalitis Virus - Another Emergent Arbovirus in the United States. (2019) (48)
Rapid latex agglutination assay using recombinant envelope polypeptide for the detection of antibody to the HIV. (1988) (47)
Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation. (1986) (47)
CD40 Ligand Trimer and IL-12 Enhance Peripheral Blood Mononuclear Cells and CD4+ T Cell Proliferation and Production of IFN-γ in Response to p24 Antigen in HIV-Infected Individuals: Potential Contribution of Anergy to HIV-Specific Unresponsiveness (2000) (47)
Eosinophil kinetics in the hypereosinophilic syndrome. (1976) (47)
Resistance to HIV–1 infection: It's in the genes (1996) (47)
High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy. (1982) (47)
Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection (1997) (47)
Relationship between alternate-day corticosteroid therapy and behavioral abnormalities. (1982) (47)
The 2009 H1N1 Pandemic Influenza Virus: What Next? (2010) (46)
Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretion. (1991) (46)
A platelet abnormality in the Chediak-Higashi syndrome of man. (1976) (46)
Cathepsin G, a Neutrophil-Derived Serine Protease, Increases Susceptibility of Macrophages to Acute Human Immunodeficiency Virus Type 1 Infection (2000) (46)
Human Immunodeficiency Virus Type 1 Bound to B Cells: Relationship to Virus Replicating in CD4+ T Cells and Circulating in Plasma (2002) (46)
Selective pressure exerted by immunodominant HIV‐1‐specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope (1999) (46)
Ocular findings in patients with neutrophil dysfunction. (1983) (46)
Disseminated candidiasis. i. an experimental model in the guinea pig. (1975) (45)
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. (1990) (45)
Immunologic reactivity in the hypereosinophilic syndrome. (1979) (45)
Accumulation of human immunodeficiency virus‐specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection (1997) (45)
Intercellular adhesion molecules (ICAM)‐1 ICAM‐2 and ICAM‐3 function as counter‐receptors for lymphocyte function‐associated molecule 1 in human immunodeficiency virus‐mediated syncytia formation (1994) (45)
A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS. (2016) (45)
Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions. (1995) (45)
Ending the global HIV/AIDS pandemic: the critical role of an HIV vaccine. (2014) (45)
The T cell receptor Vβ repertoire in HIV-1 infection and disease (1993) (45)
Cell-mediated immune responses in humans after induced infection with influenza A virus. (1977) (45)
Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome. (1986) (45)
Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. (2004) (44)
Immunologic reconstitution in the acquired immunodeficiency syndrome. (1985) (44)
Human B cell activation and cell cycle progression: stimulation with anti‐μ and Staphylococcus aureus Cowan strain I (1984) (44)
Benefits and Risks of Influenza Research: Lessons Learned (2012) (44)
Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing (2017) (44)
The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells. (2002) (44)
Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report (2016) (44)
Immunopathogenesis of HIV Infection (1993) (44)
CpG Oligonucleotides Enhance Proliferative and Effector Responses of B Cells in HIV-Infected Individuals1 (2008) (44)
NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. (1991) (44)
Prospects for an HIV vaccine: leading B cells down the right path (2011) (43)
Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. (1996) (43)
Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome. (1983) (43)
Ethics of clinical research in the developing world (2002) (43)
Malaria control, elimination, and eradication: the role of the evolving biomedical research agenda. (2009) (43)
Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes. (1983) (43)
HIV-AIDS: much accomplished, much to do (2013) (43)
Innate Immunity in HIV Infection: Enhanced Susceptibility to CD95-Mediated Natural Killer Cell Death and Turnover Induced by HIV Viremia (2007) (42)
Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy. (2005) (42)
The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system. (1987) (42)
Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up. (1980) (42)
Experimental disseminated candidiasis. II. Administration of glucocorticosteroids, susceptibility to infection, and immunity. (1975) (42)
The role of lymphoid organs in the immunopathogenesis of HIV infection (1992) (42)
The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infection in patients with Wegener's granulomatosis. (1973) (42)
The Concept of Classical Herd Immunity May Not Apply to COVID-19 (2022) (42)
In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation. (2000) (41)
Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys. (1997) (41)
Characterization of lymphocytes in bronchial lavage fluid from monkeys. (1976) (41)
Polyarteritis nodosa, hairy cell leukemia and splenosis. (1981) (41)
Activation and immunoregulation of antigen-specific human b lymphocyte responses: multifaceted role of the monocyte. (1982) (40)
Early Treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection (2017) (40)
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin (1984) (40)
A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques (2021) (40)
Research in the Context of a Pandemic (2020) (39)
Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide. (1980) (39)
Recombinant interleukin 2 and gamma-interferon act synergistically on distinct steps of in vitro terminal human B cell maturation. (1986) (39)
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. (2009) (39)
Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. (1996) (38)
Immunosuppressive and anti-inflammatory effects of glucocorticoids. (1979) (38)
Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome. Evidence for an abnormality affecting individual helper and suppressor T cells. (1985) (38)
Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis. (1974) (38)
Pathogenesis of HIV disease: opportunities for new prevention interventions. (2007) (38)
Influenza Vaccines: Good, but We Can Do Better. (2019) (38)
Recombinant interleukin-2-induced polyclonal proliferation of in vitro unstimulated human peripheral blood lymphocytes. (1986) (38)
Role for CD21 in the Establishment of an Extracellular HIV Reservoir in Lymphoid Tissues1 (2007) (37)
Conducting clinical trials in outbreak settings: Points to consider (2016) (36)
Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid. (1997) (36)
Activated human T cells can present denatured antigen. (1986) (36)
Pathogenic insights from studies of lymphoid tissue from HIV-infected individuals. (1995) (36)
Harrison's Infectious Diseases (2010) (36)
Activation of human B lymphocytes. XI. Differential effects of azathioprine on B lymphocytes and lymphocyte subpopulations regulating B cell function. (1978) (36)
Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine. (1984) (36)
Response: The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis (1988) (36)
Chronic, recurrent small-vessel cutaneous vasculitis. Clinical experience in 13 patients. (1982) (36)
Harrison's rheumatology (2010) (35)
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation (2006) (35)
What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats (2017) (35)
Unusual etiologies of fever and their evaluation. (1975) (35)
Development of a human T-cell hybridoma secreting separate B-cell growth and differentiation factors. (1984) (35)
A Randomized, Controlled, Trial of Short Cycle Intermittent Compared to Continuous Antiretroviral Therapy for the Treatment of HIV Infection in Uganda (2010) (35)
Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection. (2009) (35)
Neuropsychiatric aspects of AIDS. (1986) (34)
Necrotizing vasculitis, coronary angiitis, and the cardiologist. (1980) (34)
Sequential synergistic effect of interleukin 2 and interferon-gamma on the differentiation of a Tac-antigen-positive B cell line. (1986) (34)
Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression (1995) (34)
Pulmonary Involvement in the Collagen Vascular Diseases1,2 (2015) (34)
Astrocyte-conditioned medium stimulates HIV-1 expression in a chronically infected promonocyte clone (1990) (34)
Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes. (1991) (34)
Wegener's granulomatosis (1980) (34)
The complex challenges of HIV vaccine development require renewed and expanded global commitment (2019) (34)
Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120 (2018) (34)
PEPFAR - 15 Years and Counting the Lives Saved. (2018) (34)
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 (2013) (33)
Tracking HIV during disease progression. (1994) (33)
Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cells. (2012) (33)
Maturational characteristics of HIV-specific antibodies in viremic individuals. (2016) (33)
Toward an HIV vaccine: A scientific journey (2015) (33)
Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infections (1988) (33)
Successful renal transplantation in Wegener's granulomatosis. (1976) (33)
The Ba fragment of complement factor B inhibits human B lymphocyte proliferation. (1990) (32)
HIV‐1 infection in the lymphoid organs (1993) (32)
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells. (1993) (32)
Erysipelothrix rhusiopathiae bacteremia presenting as septic shock. (1985) (32)
The Role of Integrin α4β7 in HIV Pathogenesis and Treatment (2018) (32)
Immunopathogenesis of human immunodeficiency virus infection. (1993) (32)
Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts (2007) (31)
Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection (1991) (31)
Treatment with IL-7 Prevents the Decline of Circulating CD4+ T Cells during the Acute Phase of SIV Infection in Rhesus Macaques (2012) (31)
Cytokine regulation of acute and chronic HIV infection in vitro: from cell lines to primary mononuclear cells. (1994) (31)
Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis. (1979) (31)
Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. (1991) (31)
Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates (1982) (31)
The expanding global health agenda: a welcome development (2007) (31)
GATA-1 transcription factor transactivates the promoter for CCR5, a coreceptor for human immunodeficiency virus type 1 entry. (1999) (31)
Selective activation of antigen-specific human B cells in recently immunized individuals by nonspecific factors in the absence of antigen. (1983) (31)
Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection (1989) (31)
Nonspecific interstitial pneumonitis in patients with AIDS: radiologic features. (1987) (30)
Targeting α4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection (2014) (30)
CT of the paranasal sinuses and orbits in patients with Wegener's granulomatosis. (1987) (30)
Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities. (1976) (30)
An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals (2019) (30)
Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal. (2010) (30)
Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production. (1985) (30)
HLA Typing in Patients with Wegener Granulomatosis (1995) (30)
Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process. (1984) (30)
The Idiopathic Hypereosinophilic Syndrome (2020) (29)
Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS). (1984) (29)
Granulomatous vasculitides: distinct but related. (1977) (29)
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy. (2000) (29)
Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation (1981) (29)
A Framework for Decisions About Research with HPAI H5N1 Viruses (2013) (29)
25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (2007) (29)
Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens. (2016) (29)
Human astrocytes stimulate HIV-1 expression in a chronically infected promonocyte clone via interleukin-6. (1991) (29)
B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells. (1987) (28)
Differentiation of Promonocytic U937 Subclones into Macrophagelike Phenotypes Regulates a Cellular Factor(s) Which Modulates Fusion/Entry of Macrophagetropic Human Immunodeficiency Virus Type 1 (1998) (28)
Relationship of the genes for Chediak-Higashi syndrome (beige) and the T-cell receptor gamma chain in mouse and man. (1987) (28)
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes. (1996) (28)
Human lymphocyte surface markers. (1982) (28)
Anopheles gambiae Genome: Completing the Malaria Triad (2002) (28)
Nef, macrophages and B cells: a highway for evasion (2010) (28)
Lymphokine Production by B Cells from Normal and HIV‐Infected Individuals (1992) (28)
Paranasal sinus obliteration in Wegener granulomatosis. (1982) (28)
Leukemic B-cell precursors constitutively express functional receptors for human interleukin-1. (1989) (28)
HYDROCORTISONE, PREDNISONE, ENDOTOXIN, AND ETIOCHOLANOLONE (1975) (28)
Opioid Injection in Rural Areas of the United States: A Potential Obstacle to Ending the HIV Epidemic. (2019) (28)
Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals (2011) (27)
Activated human T cells can present alloantigens but cannot present soluble antigens. (1985) (27)
Differential effects of interleukin 2 vs B cell growth factor on human B cells. (1988) (27)
Lymphomatoid Granulomatosis and Angiocentric Lymphoma: A Spectrum of Post-Thymic T-Cell Proliferations (1989) (27)
Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems. (1981) (27)
An HIV cure: feasibility, discovery, and implementation. (2014) (26)
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit (2021) (26)
Prolonged viral suppression with anti-HIV-1 antibody therapy (2022) (26)
Wegener's Granulomatosis (1980) (26)
The direct effects of interleukin 1, interleukin 2, Interferon-α, Interferon-γ, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells (1985) (26)
HTLV type I Tax activation of the CXCR4 promoter by association with nuclear respiratory factor 1. (1999) (26)
Mechanisms of Lymphocyte Activation and Immune Regulation (1987) (26)
Immunolgic reactivity of the lung. V. Regulatory effects of antibody on the pulmonary immune response to locally administered antigen. (1977) (26)
Subpopulations of human T lymphocytes. (1980) (26)
HIV/AIDS in 1998--gaining the upper hand? (1998) (26)
Filarial parasite-specific T cell lines: induction of IgE synthesis. (1985) (25)
Basic science: Bedrock of progress. (2016) (25)
Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies (2004) (25)
Activation of human B lymphocytes. IX. Modulation of antibody production by products of activated macrophages. (1978) (25)
CORTICOSTEROIDS IN HUMAN LYMPHOCYTE‐MEDIATED CYTOTOXIC REACTIONS: EFFECTS ON THE KINETICS OF SENSITIZATION AND ON THE CYTOLYTIC CAPACITY OF EFFECTOR LYMPHOCYTES IN VITRO (1977) (25)
Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor. (1990) (24)
Neoplasm and systemic vasculitis: a case report. (1982) (24)
Retinal leakage in retinal vein occlusion: reduction after hyperbaric oxygen. (1989) (24)
Kaposi's Sarcoma of the Head and Neck in the Acquired Immune Deficiency Syndrome (1984) (24)
Emerging Pandemic Diseases: How We Got to COVID-19 (2020) (24)
Immunological reactivity of the lung: VII. Effect of corticosteroids and cyclophosphamide on the Fc receptor function of alveolar macrophages (1977) (24)
The Critical Role of Biomedical Research in Pandemic Preparedness. (2017) (24)
Induction of HIV-1 replication by allogeneic stimulation. (1999) (24)
Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma. (1984) (24)
Diagnostic and therapeutic aspects of the surgical approach to Wegener's granulomatosis. (1979) (24)
Biodefence on the research agenda (2003) (24)
Elevated levels of tumor necrosis factor-alpha in Zairian neonate plasmas: implications for perinatal infection with the human immunodeficiency virus. (1994) (24)
Comparative analysis of constitutive cytokine expression in peripheral blood and lymph nodes of HIV-infected individuals. (1994) (24)
Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function. (1984) (23)
Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals. (1976) (23)
Encyclopedia of pestilence, pandemics, and plagues (2008) (23)
Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood. (1984) (23)
The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research (2005) (23)
Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection (2019) (23)
AIDS: Let Science Inform Policy (2011) (23)
Improvement of antibody functionality by structure-guided paratope engraftment (2019) (23)
Biomedical research--an integral component of national security. (2004) (23)
The clinical use of glucocorticoids. (1983) (23)
Familial vasculitis: report of 2 families. (1994) (23)
In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. (1984) (23)
The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors. (1975) (23)
Glucocorticoids synergize with tumor necrosis factor alpha in the induction of HIV expression from a chronically infected promonocytic cell line. (1993) (23)
Computer Assisted Tomography of Orbital Lesions in Wegener's Granulomatosis (1978) (23)
Increased expression of HLA-DR antigens in hydrocortisone-treated monocytes. (1984) (22)
An HIV Vaccine: Mapping Uncharted Territory. (2016) (22)
Refocusing Research on Sexually Transmitted Infections. (2019) (22)
Human trials of AIDS vaccines: current status and future directions (1989) (22)
A Centenary Tale of Two Pandemics: The 1918 Influenza Pandemic and COVID-19, Part I. (2021) (22)
Characterization of a T4+/Leu-8+ T cell clone that directly helps B cell Ig production by secreting B cell differentiation factor. (1985) (22)
Cytokine regulation of HIV expression. (1990) (22)
The modulation of membrane Ia on human B lymphocytes. (1985) (22)
Analysis of the expression of the 4F2 surface antigen in normal and neoplastic fibroblastic human cells of embryonic and adult origin. (1985) (22)
Immunoblastic sarcoma of the central nervous system in a patient with lymphomatoid granulomatosis (1978) (22)
Visual and auditory anomalies in Chediak-Higashi syndrome. (1983) (22)
Acute Flaccid Myelitis: Something Old and Something New (2019) (22)
NIAID workshop on immunity to malaria: addressing immunological challenges (2009) (22)
Combination anti-HIV antibodies provide sustained virological suppression (2022) (22)
Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function. (1977) (21)
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7 (2018) (21)
Less common manifestations and presentations of Wegener's granulomatosis. (1992) (21)
Virologic and immunologic events in primary HIV infection (2004) (21)
Immunopathology and pathogenesis of human immunodeficiency virus infection. (1991) (21)
Herpes zoster in patients with treated Wegener's granulomatosis. A possible role for cyclophosphamide. (1980) (21)
Lymphocyte-mediated cytotoxicity against human allogeneic and autologous lymphoid targets after concanavalin A-activation of cytotoxic effector cells. (1977) (21)
Emerging infectious diseases: a clear and present danger to humanity. (2004) (21)
Host defense against Mycobacterium-avium complex. (1988) (21)
Host-based antipoxvirus therapeutic strategies: turning the tables. (2005) (21)
Investing to meet the scientific challenges of HIV/AIDS. (2009) (20)
Identification of a receptor for high molecular weight human B cell growth factor. (1988) (20)
Optimal immunity to HIV--natural infection, vaccination, or both? (1991) (20)
Classification and Prospective Clinical Experience (1986) (20)
Lymphocyte populations in acute viral gastroenteritis (1976) (20)
Immunology research: challenges and opportunities in a time of budgetary constraint (2007) (20)
Cardiovascular effects and safety of intravenous and intramuscular pentamidine isethionate. (1987) (20)
Transmission of drug-resistant strains of HIV-1: unfortunate, but inevitable (1999) (20)
Characterization of the direct effects of cyclophosphamide on cell-mediated immunological responses. (1977) (20)
The AIDS research model: implications for other infectious diseases of global health importance. (2001) (20)
Human B lymphocyte function: cell triggering and immunoregulation. (1982) (20)
The hypereosinophilic syndrome: dramatic response to therapeutic intervention. (1977) (19)
HIV cure research: a formidable challenge (2015) (18)
Emerging and Reemerging Infectious Diseases: The Dichotomy Between Acute Outbreaks and Chronic Endemicity (2017) (18)
COVID-19: The therapeutic landscape (2021) (18)
MAdCAM costimulation through Integrin-α4β7 promotes HIV replication (2018) (18)
Thoracic manifestations of the acquired immune deficiency syndrome. (1984) (18)
Pandemic Zika: A Formidable Challenge to Medicine and Public Health (2017) (18)
Dramatic remissions in severe systemic necrotizing vasculitis (SNV) with cyclophosphamide (CY) therapy (1979) (18)
Species-Specific Differences in the Expression and Regulation of α4β7 Integrin in Various Nonhuman Primates (2015) (17)
HIV-1 gp120: A Target for Therapeutics and Vaccine Design. (2015) (17)
Leukotriene C4 produced by a human T-T hybridoma suppresses Ig production by human lymphocytes. (1988) (17)
Trapped but still dangerous (1995) (17)
Apparent direct cellular cytotoxicity mediated via cytophilic antibody. Multiple Fc receptor bearing effector cell populations mediating cytophilic antibody induced cytotoxicity. (1977) (17)
Cell-Mediated Cytotoxicity in Recurrent Herpes Simplex Virus Infections in Man (1977) (17)
The Role of US Government Agencies in Vaccine Research And Development (1998) (16)
Human B-lymphocyte function : activation and immunoregulation (1982) (16)
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses (2022) (16)
Human bone marrow lymphocytes. III. Polyclonal activation of B lymphocytes in human bone marrow measured by a direct plaque-forming cell assay. (1977) (16)
Short Communication HTLV Type I Tax Activation of the CXCR4 Promoter by Association with Nuclear Respiratory Factor 1 (1999) (16)
Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line. (1986) (16)
Reimagining the Research Approach to Tuberculosis† (2018) (16)
An Historical Antecedent of Modern Guidelines for Community Pandemic Influenza Mitigation (2009) (16)
Analysis of Fcγ receptors on human peripheral blood leukocytes by flow microfluorometry. I. Receptor distributions on monocytes, Tγ cells and cells labeled with the 3A1 anti‐T cell monoclonal antibody (1982) (16)
Early treatment of SIV plus macaques with an alpha(4)beta(7) mAb alters virus distribution and preserves CD4(+) T cells in later stages of infection (16)
MSM, AIDS research activism, and HAART (2012) (15)
Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy. (2020) (15)
Comprar Harrison's Principles of Internal Medicine, Self-Assessment and Board Review | Joseph Loscalzo | 9780071496193 | Mcgraw-Hill Education (2008) (15)
Integrin alpha(4)beta(7) expression on peripheral blood CD4(+) T cells predicts HIV acquisition and disease progression outcomes (15)
The world must build on three decades of scientific advances to enable a new generation to live free of HIV/AIDS. (2012) (15)
Diadenosine 5',5'''-p1,p4-tetraphosphate deficiency in blood platelets of the Chédiak-Higashi syndrome. (1985) (15)
The Extended Impact of Human Immunodeficiency Virus/AIDS Research (2018) (15)
The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans (1985) (15)
Corticosteroids in autoimmune disease. (1983) (15)
Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation. (1980) (14)
Development of a human T-T cell hybridoma secreting B cell growth factor (1982) (14)
Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward (2012) (14)
Suppression of antibody synthesis. I. Evidence for a circulating inhibitor of antibody synthesis demonstrable at the cellular level. (1971) (14)
Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles. (2019) (14)
A phase I trial of recombinant human interferon-γ in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS) (1989) (14)
Short Communication: The Role of Dendritic Cells in the Infection of CD4+ T Cells with the Human Immunodeficiency Virus: Use of Dendritic Cells from Individuals Homozygous for the Δ32CCR5 Allele as a Model (1998) (14)
The acquired immune deficiency syndrome. The ever-broadening clinical spectrum. (1983) (14)
AIDS in 1996. Much accomplished, much to do. (1996) (14)
Diffuse histiocytic lymphoma in a patient treated with cyclophosphamide for Wegener's granulomatosis. (1984) (14)
Classics in medicine (1994) (14)
Transforming growth factor-beta is a potent negative regulator of human lymphocytes. (1991) (14)
The Chronically Infected Promonocytic Cell Line U1: A Model of HIV Expression Regulated by Cytokines (1993) (14)
Wegener's granulomatosis. (1982) (14)
Dendritic cells express and use multiple HIV coreceptors. (1997) (13)
Facial erysipelas in the immunocompromised host. Report of two cases. (1981) (13)
Bone Marrow Plasma Cells Are a Primary Source of Serum HIV-1–Specific Antibodies in Chronically Infected Individuals (2015) (13)
Wegener's granulomatosis: studies in eighteen patients and a review of the literature. 1973. (1994) (13)
NIH Response to Open Letter (2005) (13)
Activation of human B lymphocytes. XV. Spontaneously occurring and mitogen-induced indirect anti-sheep red blood cell plaque-forming cells in normal human peripheral blood. (1980) (13)
AIDS–challenges to basic and clinical biomedical research (1989) (13)
Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia. (1989) (13)
Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation. (1981) (13)
Current therapy in allergy and immunology 1983-1984 (1983) (13)
Buerger's disease in a young woman. (1986) (13)
Host factors in the pathogenesis of HIV disease. (1996) (13)
Development and characterization of interleukin-2-independent antigen-specific human T cell clones that produce multiple lymphokines. (1984) (13)
Activation, proliferation, and differentiation of circulating B cells in autoimmune thyroid disease. (1985) (13)
Harrison Principios De Medicina Interna, 2 Vols. + Dvd 18ª Ed. (2012) (13)
Immunological reactivity of the lung II. Cytotoxic effector function of pulmonary mononuclear cell subpopulations. (1976) (12)
Host factors that affect sexual transmission of HIV. (1998) (12)
Progress in drug therapies for HIV infection. (1988) (12)
HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics. (2021) (12)
The Chediak-Higashi gene in humans. III. Studies on the mechanisms of NK impairment. (1983) (12)
Therapeutic approaches to patients with AIDS. (1985) (12)
Smallpox immunization in the 21st century: the old and the new. (2003) (12)
Immunology of aids: Approaches to understanding the immunopathogenesis of HIV infection (1989) (12)
Pulmonary vasculitis. (1986) (12)
Erratum: Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates (Proceedings of the National Academy of Sciences of the United States of America (December 9, 2003) 100, 25 (15011-15016)) (2004) (11)
Vasculitis: new insights amid old enigmas. (1979) (11)
STIMULATION OF PHAGOCYTOSIS BY A T CELL LYMPHOMA-DERIVED LYMPHOKINE (1982) (11)
The vasculitides. (1981) (11)
IMMUNOLOGICAL FEATURES OF WEGENER'S GRANULOMATOSIS (1974) (11)
The T cell receptor V beta repertoire in HIV-1 infection and disease. (1993) (11)
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4β7 and promotes cellular activation and infection. (2020) (11)
Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques (2019) (11)
Reaching everyone, everywhere with life-saving vaccines (2017) (11)
Early idiopathic hemochromatosis with absent stainable bone marrow iron stores (1978) (11)
Update on and Future Directions for Use of Anti–SARS-CoV-2 Antibodies: National Institutes of Health Summit on Treatment and Prevention of COVID-19 (2021) (11)
Cytokine Cascades in HIV Infection (1996) (11)
AIDS: immunopathogenic mechanisms and research strategies. (1987) (11)
Differential sensitivity of human lymphocyte subpopulations to azathioprine. (1979) (11)
Immunologic aspects of the acquired immunodeficiency syndrome (1985) (11)
Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease (1982) (11)
Pharmacokinetics of lymphocyte-derived and recombinant DNA-derived interleukin-2 after intravenous administration to patients with the acquired immunodeficiency syndrome. (1985) (11)
Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease (1982) (11)
The Role of the Virtuous Investigator in Protecting Human Research Subjects (2016) (11)
Stages in the progression of HIV infection in chimpanzees. (1987) (11)
Human Immunodeficiency Virus Type 1 (HIV-1) Non-B Subtypes Are Similar to HIV-1 Subtype B in that Coreceptor Specificity Is a Determinant of Cytopathicity in Human Lymphoid Tissue Infected Ex Vivo (2001) (11)
Corticosteroid-induced modulation of immunoglobulin secretion by human B lymphocytes: potentiation of background mitogenic signals. (1982) (11)
Quantitative and qualitative effects of cyclophosphamide administration on circulating polymorphonuclear leucocytes. (1976) (11)
Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics (2021) (11)
Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferation (1985) (10)
Radiation therapy of midline granuloma (1977) (10)
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to alpha4beta7 (2018) (10)
Chromobactehum violaceum Infectious and Chronic Granulomatous Disease (1983) (10)
Role of Implementation Science: Linking Fundamental Discovery Science and Innovation Science to Ending the HIV Epidemic at the Community Level. (2019) (10)
Focusing to achieve a world without AIDS. (2015) (10)
Combination therapy for HIV infection: getting closer. (1992) (10)
Benchmarks for antiretroviral therapy. (2000) (10)
MAdCAM costimulation through Integrin-alpha(4)beta(7) promotes HIV replication (2018) (10)
The search for an HIV vaccine, the journey continues (2020) (10)
Evidence for susceptibility of intrathymic T cell precursors to human immunodeficiency virus infection: a mechanism for T4 (CD4) lymphocyte depletion. (1990) (10)
Antigen-induced human T cell help. Precursor frequency, radiation sensitivity, and allogeneic effects. (1983) (10)
Regulation of human B-cell activation, proliferation, and differentiation by soluble factors (1984) (10)
Nocardia astéroïdes sinusitis. Presentation as a trimethoprim-sulfamethoxazole responsive fever of unknown origin. (1977) (10)
Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma. (1986) (10)
Suppression of antibody synthesis. II. The effect of carrier-specific cellsupon haptenic competition. (1971) (10)
Ending the HIV Pandemic: Optimizing the Prevention and Treatment Toolkits. (2019) (10)
Defective polymorphonuclear leukocyte chemotaxis and bactericidal capacity in a boy with recurrent pyogenic infections. (1976) (9)
Lithium carbonate for recurrent fever and neutropenia. (1981) (9)
The relationship between immunization and circulating antigen-specific plaque-forming cells. (1983) (9)
Harrison's Gastroenterology and Hepatology (2010) (9)
Current strategies in the treatment of HIV infection. (2002) (9)
An elusive soluble suppressor (1995) (9)
Bioterrorism: defining a research agenda. (2002) (9)
NIH conference. The acquired immunodeficiency syndrome: an update. (1985) (9)
The human autologous mixed lymphocyte reaction. II. Analysis of activation and proliferation. (1982) (9)
Human B-cell proliferation in response to recombinant interleukin 2 is not due to T-cell help. (1985) (9)
Different requirements for Ia-bearing accessory cells in mitogen versus antigen induction of human B-cell responses. (1983) (9)
Host defense againstMycobacterium-avium complex (1988) (9)
The activation, proliferation, and differentiation of human B lymphocytes. (1987) (9)
Acquired immunodeficiency syndrome may present as severe restrictive lung disease. (1989) (9)
Current Concepts Influenza Vaccines for the Future (2010) (8)
Ending the HIV Epidemic in the United States: Closing the Implementation Gaps (2018) (8)
Harrison's Infectious Diseases, 2/E (2013) (8)
Modulation of human B cell responses by a monoclonal antibody to an activation antigen 4F2. (1984) (8)
Continuous flow leukapheresis induces expression of stress genes in lymphocytes: impact on microarray analyses. (2003) (8)
The revolution in clinical immunology. (1981) (8)
Corticosteroids and circulating lymphocytes. (1975) (8)
Achieving an AIDS-free World: Science and Implementation (2013) (8)
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy (2021) (8)
IMMUNOPATHOGENESIS OF HIV INFECTION 1 (1998) (8)
Dengue: The Continual Re-Emergence of a Centuries-Old Disease (2013) (8)
Correlation with increased IL-7 (2016) (8)
Antiretroviral therapy and immunologic reconstitution in AIDS. (1987) (8)
Preface: Evolving Ethical Issues Over the Course of the AIDS Pandemic (2012) (8)
Addressing the Tuberculosis Epidemic: 21st Century Research for an Ancient Disease (2018) (7)
Chromobacterium violaceum infectious and chronic granulomatous disease. (1983) (7)
Salmonella Susceptibility (2010) (7)
Idiopathic midline granuloma. (1982) (7)
Monkeypox - Past as Prologue. (2022) (7)
Synergy of helper factors in the differentiation of in vivo-preactivated antigen-specific human B cells. (1985) (7)
Achieving an AIDS-free world: science and implementation (2013) (7)
ddI--a good start, but still phase I. (1990) (7)
WEGENER GRANULOMATOSIS. REPLY (1992) (7)
Comprar Harrison's Infectious Diseases | Anthony S. Fauci | 9780071702935 | Mcgraw-Hill Education (2010) (7)
200 Leukotriene B4, C4 and D4 generation by human eosinophils (1983) (7)
The development of an AIDS vaccine: progress and promise. (1988) (7)
2005 Robert H. Ebert Memorial Lecture Emerging and Re-emerging Infectious Diseases: The Perpetual Challenge (2005) (7)
Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection. (2019) (7)
Antiviral immunity in HIV-1 infected long-term non-progressors (LTNPs) (1996) (7)
Human immunodeficiency virus disease : AIDS and related disease (2008) (7)
Suppression of the generation of human con A-induced cytotoxic effector cells by con A-activated suppressor cells. (1978) (7)
A platelet abnormality in the Chediak-Higashi syndrome of man (1976) (6)
Two-dimensional Echocardiographic Assessment of the Idiopathic Hypereosinophilic Syndrome (2005) (6)
Pillars Article: production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986. 163: 1037-1050. (2014) (6)
Wegener's granulomatosis and other systemic granulomatous conditions. (1990) (6)
The pathology of idiopathic midline destructive disease (IMDD) in the eyelid. (1983) (6)
123 – The Immunology of Human Immunodeficiency Virus Infection (2015) (6)
Comprar Harrison's Manual of Medicine | Dennis Kasper | 9780071477437 | Mcgraw-Hill Education (2009) (6)
The NIH-led research response to COVID-19 (2023) (6)
Both Memory and CD 45 RA 1 / CD 62 L 1 Naive CD 4 1 T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals (1999) (6)
Síndromes de las vasculitis (2007) (6)
Current Studies Examining Regulation of the Human B Cell Cycle (1987) (6)
Early human B cell signatures of the primary antibody response to mRNA vaccination (2022) (6)
Glucocorticoid effects on circulating human mononuclear cells. (1979) (6)
Role of T-cell trafficking in the pathogenesis of HIV disease (2019) (6)
Blocking α4β7 integrin delays viral rebound in SHIVSF162P3-infected macaques treated with anti-HIV broadly neutralizing antibodies (2021) (6)
Human immunodeficiency virus. Trapped but still dangerous. (1995) (6)
Histopathology of ocular changes in chronic granulomatous disease. (1983) (6)
Antigen-specific human B-cell responses: modulation by immunoregulatory T-cell subsets. (1983) (6)
Association Between Human Immunodeficiency Virus Infection and Cardiovascular Diseases: Finding a Solution to Double Jeopardy. (2017) (5)
Therapeutic approach to the vasculitic syndromes. (1986) (5)
Monocyte t cell interactions in the immuno regulation of human b cell reactivity (1980) (5)
Viral persistence in HIV infection: much known, much to learn. (2013) (5)
lmmunoregulation in autoimmunity (1980) (5)
Decade of Vaccines. Foreword. (2013) (5)
Meeting the Challenge of Epidemic Chikungunya. (2016) (5)
Advances in host defense mechanisms. Volume 1. Phagocytic cells. (1982) (5)
Comprar Harrison's Manual Of Medicine 19th Ed. | D. Kasper | 9780071828529 | MCGRAW HILL (2016) (5)
CHAPTER 2 – POKEWEED MITOGEN-INDUCED PFC RESPONSES OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES: REGULATION OF B-CELL TRIGGERING (1979) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
2019: A Banner Year for Tuberculosis Research. (2020) (5)
The Acquired Immune Deficiency Syndrome: The Ever-Broadening Clinical Spectrum. (1983) (5)
Peripheral Neuropathy in Chediak-Higashi Syndrome (1986) (5)
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses (2023) (5)
Introducción al sistema inmunitario (2007) (5)
Comprar Harrison Principios De Medicina Interna, 2 Vols. + Dvd 18ª Ed. | Eugene Braunwald | 9786071507273 | MCGRAW HILL (2012) (5)
Infection by HIV Chemokine Receptor 5 Expression and Cells : CXC Chemokine Receptor 4 and CC Progenitor + Peripheral Blood-Derived CD 34 (1998) (4)
Biochemical and Biological Characterization of a Dodecameric CD 4-Ig Fusion Protein IMPLICATIONS FOR THERAPEUTIC AND VACCINE (2002) (4)
Audio Interview: A Covid-19 Conversation with Anthony Fauci. (2021) (4)
Catalysing HIV/TB research: a meeting report (2009) (4)
11 The aids epidemic: Demographic aspects, population biology, and virus evolution (1998) (4)
NIH conference. Immunomodulators in clinical medicine. (1987) (4)
Heparin and lymphocyte kinetics: use in studies on the mechanisms of corticosteroid-induced peripheral lymphocytopenia. (1976) (4)
It Ain't Over Till It's Over … but It's Never Over - Emerging and Reemerging Infectious Diseases. (2022) (4)
Demonstration of major histocompatibility complex restriction in man using an antigen-specific proliferating T cell clone. (1982) (4)
Head and neck manifestations of histiocytic medullary reticulosis (1978) (4)
In Memoriam: Robert M. Chanock, MD, 1924–2010. (2011) (4)
Refocusing Human Microbiota Research in Infectious and Immune-mediated Diseases: Advancing to the Next Stage. (2020) (4)
Prevention of HIV Transmission Universal Voluntary Testing and Treatment for (2009) (4)
Translating Research into Therapies (2012) (4)
Transforming biomedical research to develop effective TB vaccines: the next ten years. (2012) (4)
The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells. (1985) (4)
Overview of clinical syndromes and immunology of AIDS. (1984) (4)
Idiopathic CD 4 + T Lymphocytopenia is Associated with Increases in Immature / Transitional B Cells and Serum Levels of IL-7 Short title : ICL linked to abnormal B cells and elevated IL-7 (2006) (4)
Immunogenic Properties of Human Gamma Globulin Free of Endotoxin Contamination (1971) (4)
Comprar Harrison Manual de Medicina Interna 18ed | Dan Longo | 9786071509505 | Mcgraw-Hill Interamericana (2013) (4)
The effects of interleukin-1, interleukin-2, alpha-interferon, and gamma-interferon on human B lymphocytes. (1984) (4)
Chromobacterium violaceum infections and chronic granulomatous disease. (1983) (4)
Early treatment of HIV-1 infection (1998) (4)
Complete hematologic and hepatic recovery in a patient with chloramphenicol hepatitis-pancytopenia syndrome. (1982) (4)
Letter: Midline granuloma or Wegener's granulomatosis. (1976) (3)
The effect of in vivo hydrocortisone (OHC) on in vitro lymphocyte function in humans (1973) (3)
B-cell abnormalities in AIDS. (1984) (3)
The role of dendritic cells in the infection of CD4+ T cells with the human immunodeficiency virus: use of dendritic cells from individuals homozygous for the delta32CCR5 allele as a model. (1998) (3)
Cytotoxic cellular immunity and cytomegalovirus lessons from studies of the acquired immunodeficiency syndrome and immunosuppressed allograft recipients (1985) (3)
Emerging and Re-Emerging Infectious Diseases: The Perpetual Challenge to Global Health (2004) (3)
The vasculitic syndromes. (1982) (3)
An HIV vaccine: breaking the paradigms. (1996) (3)
NIH research: Think globally (2015) (3)
Immunologic aspects of cardiovascular disease. (1982) (3)
Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine (2021) (3)
Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus (3)
The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis. (1988) (3)
A Universal Flu Vaccine Is Vital. (2018) (3)
Wegener's granulomatosis. (1991) (3)
NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection. (1989) (3)
Biochemical characterization of human B-cell growth factor (BCGF)☆☆☆ (1982) (3)
Anti-PF4 antibodies associated with disease severity in COVID-19 (2022) (3)
Thoracic mass lesions in immuno-incompetent patients. (1982) (3)
Characterization of the cellular immune response following in vivo immunization with pneumococcal polysaccharides in man. (1983) (3)
Impact of Biomedical Research on the AIDS Epidemic (1992) (3)
Differentiation of Promonocytic U 937 Subclones into Macrophagelike Phenotypes Regulates a Cellular Factor ( s ) Which Modulates Fusion / Entry of Macrophagetropic Human Immunodeficiency Virus Type 1 (1997) (3)
Activation of human B lymphocytes. XVII. Synergy between nonspecific and specific signals in the antigen-specific responses of human B cells. (1981) (3)
Fighting infectious disease threats via research: a talk with Anthony S. Fauci. (1996) (3)
From mRNA sensing to vaccines (2021) (3)
AIDS: newer concepts in the immunopathogenic mechanisms of human immunodeficiency virus disease. (1995) (3)
Immunity to Influenza: Catching a Moving Target To Improve Vaccine Design (2019) (3)
Dichotomy between antigen and mitogen induced t cell help in human b cell activation (1982) (3)
T cell homeostasis in HIV infection: part of the solution, or part of the problem? (1993) (3)
The National Institute of Allergy and Infectious Diseases' asthma research programs: a retrospective. (2007) (3)
The Forgotten Forefather: Joseph James Kinyoun and the Founding of the National Institutes of Health (2012) (3)
Human cyclic neutropenia (1981) (3)
Successful management of hepatic abscesses by percutaneous catheter drainage in chronic granulomatous disease. (1986) (3)
Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness (2022) (3)
Victories against AIDS have lessons for COVID-19 (2021) (3)
Functional and biochemical characterization of B-cell differentiation factor (BCDF) produced by an HTLV-I-transformed human T-cell clone and demonstration of specific binding of the factor to a BCDF responsive cell line. (1987) (3)
Immunopathogenic mechanisms of human immunodeficiency virus disease: implications for therapy. (1995) (3)
Response to: "Rescuing the NIH before it is too late". (2006) (2)
Research sheds light on treatment interruption. (2001) (2)
Letter: Immunological features of Wegener's granulomatosis. (1974) (2)
Interferon-gamma induces light chain synthesis in interleukin 2 stimulated human B cells. (1986) (2)
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
Surgical aspects of systemic necrotizing vasculitis. (1985) (2)
Cytokines and Immunoregulatory Factors in the Pathogenesis of HIV Infection: TNF Effects (1992) (2)
Expression of Chemokine Receptors CXCR4 (1998) (2)
The Spectrum of Vasculitis (2020) (2)
The Jules Bordet Lecture. Immunopathogenesis of HIV infection. (1993) (2)
Persistently elevated abnormal B‐cell subpopulations and anti‐core antibodies in patients co‐infected with HIV/HCV who relapse (2015) (2)
7 – Immunopathologic Mechanisms of Human Immunodeficiency Virus (HIV) Infection (1991) (2)
Clinical Effects of Immunosuppressive Agents: Targets and Mechanisms (1983) (2)
Authorsʼ reply to correspondence by Le and Farrar (2011) (2)
Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases (2003) (2)
Granulomatous hepatitis. (1976) (2)
Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells. (1978) (2)
Production of monoclonal antibody recognizing a subpopulation of human B lymphocytes producing B cell growth factor (BCGF) (1986) (2)
A new series on the revolution in immunology. (1987) (2)
US puts flu vaccines on trial. Interview by Declan Butler. (2009) (2)
Letter: Monocytopenia after prednisone. (1975) (2)
Defining and Defeating the Intolerable Burden of Malaria III. Progress and Perspectives (2007) (2)
A Centenary Tale of Two Pandemics: The 1918 Inﬂuenza Pandemic and COVID-19, Part II. (2021) (2)
KL01 Ending the HIV/AIDS Pandemic: From Scientific Advances to Public Health Implementation (2013) (2)
[The nephrotic syndrome in congenital syphilis]. (1981) (2)
N-acetyl-cysteine is a potent suppressor of human immunodeficiency virus transcription in persistently infected cells. (1992) (2)
Dengue vaccine clinical trials in India - An opportunity to inform the global response to a re-emerging disease challenge. (2019) (2)
Infectious complications complications of cyclophosphamide treatment for vasculitis (1989) (2)
Immunologic Reactivity of the Lung (1977) (2)
15. Differential effects of in vivo hydrocortisone on human T cell subpopulations (1978) (2)
CHAPTER 19 – EFFECT OF HYDROCORTISONE ON THE KINETICS AND FUNCTION OF PERIPHERAL BLOOD IMMUNOREGULATORY CELLS IN MAN (1979) (2)
The scientific agenda for AIDS. (1988) (2)
Production of phagocytosis-inducing factor and expression of 4B4 antigen by cloned human T cells before and after transformation with HTLV-I. (1988) (2)
Fitting a vaccine into the HIV prevention landscape (2021) (2)
Strategies for Preventing HIV Transmission—Reply (2009) (2)
CYTOLYTIC T LYMPHOCYTES IN MIXED LYMPHOCYTE CULTURE (1981) (2)
Pathogenic Mechanisms of HIV Disease: The Role of Viral Replication and Immune Activation (2005) (2)
Pharmacologic regulation of HIV expression. (1992) (1)
103 HIV-1 gp120 Interactions With the Gut Homing Receptor Integrin α4β7 on CD4+ T Cells (2012) (1)
Response: HIV Quasispecies and Resampling. (1996) (1)
Communications Antigenic Competition at the Cellular Level: Response of Rabbit Lymph Node Cells to the Trinitrophenyl and P-Arsanilie Haptens (1971) (1)
Characterization of an early thymocyte cell line which is chronically infected with the human immunodeficiency virus. (1991) (1)
The ASCI, the spring meetings, and growing up in academic medicine: a personal perspective. (2008) (1)
Development of Effective Vaccines Commentary against Pandemic Influenza (2006) (1)
Regulation of Human B Cell Growth (1989) (1)
Wegener granulomatosis [3] (1992) (1)
Challenges and similarities in HIV, COVID-19 crises: a Q&A with Anthony Fauci, MD. (2020) (1)
Investing To Meet The Scientific Challenges Of (2009) (1)
Reply to Brundage and Shanks (2007) (1)
117 Ending the HIV/AIDS Pandemic: A Realistic Goal (2012) (1)
Regulation of Human B Cell Function (1988) (1)
Screening for HIV infection in sexually transmitted disease clinics. (1988) (1)
New Science Aimed at an Ancient Killer (1995) (1)
HIV prevention research: progress and challenges in the new millennium (1969) (1)
Reports on nevirapine threaten public health (2005) (1)
Acute Renal Failure (1987) (1)
Immunoregulation by Human Lymphocyte Subpopulations (1980) (1)
Comprar Harrison's Rheumatology | Carol Langford | 9780071741439 | Mcgraw-Hill Education (2010) (1)
37 – Human T Cell Clones Reactive with Soluble Antigens: Methodology, Specificity, and MHC Restriction (1982) (1)
Effect of alternate day prednisone therapy on human lymphocyte subpopulations (1974) (1)
CHAPTER 23 – ABERRANT REGULATION OF B-CELL FUNCTION IN IMMUNOLOGICALLY MEDIATED DISEASES: SYSTEMIC LUPUS ERYTHEMATOSUS AND SARCOIDOSIS (1979) (1)
Infection of CD4+ Primary Cell Lines and Induction of HIV (1993) (1)
Biomedical research in an era of unlimited aspirations and limited resources. (1996) (1)
Human T4+ lymphocytes produce a phagocytosis-inducing factor distinct from α- and γ-interferon (1985) (1)
Antigenic competition at the cellular level: response of rabbit lymph node cells to the trinitrophenyl and p-arsanilic hapTENS. (1971) (1)
OBJECTIVE PROGNOSTIC FACTORS FOR PATIENTS WITH PNEUMOCYSTIS CARINII PNEUMONIA AND THE ACQUIRED IMMUNODEFICIENCY SYNDROME (1987) (1)
C105 Glycosylation in HIV Transmission (2013) (1)
Track A Basic Science (2012) (1)
A view from Washington through the eyes of an AAP physician-scientist: 2007 Association of American Physicians George M. Kober Medal. (2007) (1)
P-C19 The in vivo effects of Anti-a4b7 in rhesus macaques during acute and chronic infection (2017) (1)
EFFECT OF VIRUS INFECTION ON POLYMORPHONUCLEAR LEUCOCYTES (1977) (1)
Emerging concepts in the management of vasculitic diseases. (1994) (1)
A living history of AIDS vaccine research. (2009) (1)
H-106 Sustained ART-free HIV remission: Obstacles and opportunities (2018) (1)
Host Factors in the Immunopathogenesis of HIV Disease (1995) (1)
MULTIPLE SUBPOPULATIONS OF LYMPHOID CELLS REGULATING HUMAN B CELL FUNCTION (1979) (1)
US and Cuban Scientists Forge Collaboration on Arbovirus Research. (2018) (1)
MAdCAM signaling through integrin α4β7 modulates surface expression of CCR5 and markers of CD4+ T cell activation. (2016) (1)
Activation and immunoregulation of human B lymphocytes. (1984) (1)
HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells (2006) (1)
Plaque-forming cell assays for human B cells (1981) (1)
Individuals and CCR 5 in HIV-1-Infected and Uninfected Expression of Chemokine Receptors CXCR 4 (1998) (1)
Forty years of investment in HIV research: progress towards ending the HIV pandemic and preparation for future pandemics (2022) (1)
Inhibition of polyclonal B cell activation by hydrocortisone (HC)-sensitive suppressor monocytes in sarcoidosis (1978) (1)
Clinical characteristics and outcomes of South-East Asian patients with Takotsubo ( stress-induced ) cardiomyopathy (2003) (1)
Relationship between the Size of the Human Immunodeﬁciency Virus Type 1 (HIV-1) Reservoir in Peripheral Blood CD4 + T Cells and CD4 + :CD8 + T Cell Ratios in Aviremic HIV-1– Infected Individuals Receiving Long-Term Highly Active Antiretroviral Therapy (2002) (1)
Early idiopathic hemochromatosis with absent stainable bone marrow iron stores. (1978) (1)
Immunoregulation in autoimmunity. (1981) (1)
The challenges of an HIV vaccine enterprise - Response (2004) (1)
Chapter 257. Tumours of the large and small intestine (1994) (1)
CD 8 ' T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity ( cytotoxic T lymphocyte / T-cell abnormalities ) (1)
Reversal with IL-10 Unbalanced Th1-Type T Cell Cytokine Pattern: T Cells Exhibiting an + CD4 + with HLA-DR Active Wegener's Granulomatosis Is Associated (1998) (1)
CCR5 Signal Transduction in Macrophages by Human Immunodeficiency Virus and Simian Immunodeficiency Virus Envelopes (2000) (1)
Alternative cytokines in the immunoregulation of the human B cell cycle. (1989) (1)
Harrison's 14 CD-ROM (2000) (1)
Relationship between expression of Fcγ receptors or la antigens and cytolytic activities of alloactivated human T cells (1983) (1)
IMMUNOREGULATION OF HUMAN B LYMPHOCYTE FUNCTION BY PRODUCTS OF HYBRIDIZED AND CLONED T CELLS (1983) (1)
Battling Ebola: the virus and the fear. (2014) (1)
Reply to kilbourne. (2009) (1)
Efficient macrophage isolation of human immunodeficiency virus from peripheral blood leukocytes from healthy seropositive individuals: implications for cell tropism. (1989) (1)
Temporal Aspects Of Hiv Dna And Rna Synthesis And Tissue Distribution During Hiv Infection (1993) (1)
Role of CD8+ T Lymphocytes in the Pathogenesis of HIV Infection (1992) (1)
GENERAL DISCUSSION: CLINICAL IMPLICATIONS IN THE STUDY OF IN VITRO B CELL FUNCTION. II. (1979) (0)
Global Health and Infectious Diseases: A Look to the Future (2008) (0)
395 The effect of elective C-section, preterm labor and chorioamnionitis on fetal lymphocyte activation and susceptibility to HIV infection (2001) (0)
Protection against repeated vaginal SHIV challenges by a combination of VRC01 and an anti-α4β7 antibody (2018) (0)
Correction (2002) (0)
Pandemic Preparedness and Response: Lessons from COVID-19. (2023) (0)
Correction (2002) (0)
Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report (2022) (0)
Point man. Interview by Jeff Berry. (2011) (0)
Comprar Harrison Manual de Medicina 19ª Ed. | D. Kasper | 9786071514097 | MCGRAW HILL (2017) (0)
Information , Inspiration and Advocacy for People Living with HIV / AIDS (0)
of the Malignant T Cell in Sezary Syndrome and Mycosis Fungoides (1981) (0)
Correction (2020) (0)
Cytotoxic effector capacity of bone marrow mononuclear cells. (1976) (0)
Comprar Harrison Manual de Medicina 19ª Ed. | D. Kasper | 9786071514097 | MCGRAW HILL (2017) (0)
IN VITRO REACTIVATION OF HIV-1 FROM LATENTLY INFECTED, RESTING CD4+ T CELLS BY HTLV-I-INFECTED CELL-DERIVED SOLUBLE FACTORS. (1999) (0)
Leukotriene C/sub 4/ (LTC/sub 4/) produced by a human T-T hybridoma suppresses pokeweed mitogen (PWM) induced immunoglobulin (Ig) production by human mononuclear cells (1986) (0)
Etiology of the acquired immunodeficiency syndrome (1985) (0)
THE HEMODYNAMIC EFFECTS AND SAFETY OF IV PENTAMIDINE (1986) (0)
Immuno-incompetent Patients* (2017) (0)
Chronic, Recurrent Small-Vessel Cutaneous Vasculitis-Reply (1982) (0)
Book reviews (1993) (0)
25 years of AIDS. Interview by Simon Noble. (2006) (0)
THE ROLE OF SEQUENTIAL GALLIUM SCANNING IN AIDS PATIENTS DURING TREATMENT FOR PNEUMOCYSTIS CARINII PNEUMONIA (1987) (0)
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination (2022) (0)
In Memoriam: Edwin D. Kilbourne, MD, 1920–2011 (2011) (0)
Correction (1983) (0)
The Ebola Epidemic of 2014–2015 (2016) (0)
Current therapy in allergy, immunology, and rheumatology, 1985-1986 (1985) (0)
Alteration of T lymphocyte subpopulations and presence of suppressor monocytes in tuberculosis (TB): The effects of anti-TB therapy (1979) (0)
The revolution in the approach to allergic and immunologic diseases. (1985) (0)
Evidence for CC-Chemokine-Dependent and to Replicate and Transmit HIV Infection : Stimulation on the Ability of Dendritic Cells Differential Effects of CD 40 Ligand / Trimer (1999) (0)
The Challenge of Pandemic Preparedness (2017) (0)
Efficient inhibition of HIV entry-1 virus by a new fusion protein with cd4 (2002) (0)
Concise review: the polypill in cardiovascular disease prevention (2007) (0)
Vaccination and the Lasker Awards: Enduring Legacies. (2015) (0)
Letter from Anthony Fauci to Joshua Lederberg (1988) (0)
Correction (2019) (0)
TGF-t 3 Suppresses IL-2-dependent T Cell Proliferation and Partially Inhibits IL-2R and Transferrin Receptor Expression (2003) (0)
ACTIVATION OF HUMAN B LYMPHOCYTES I. Direct P laque-Forming Cell Assay for the Measu remen t of Polyclonal Activation and Antigenic S t imula t ion of H u m a n B Lymphocytes (2003) (0)
Infectious complications of cyclophosphamide treatment for vasculitis. (1989) (0)
EARLY TREATMENT OF HIV-1 INFECTION. AUTHOR'S REPLY (1998) (0)
The development of candidate HIV vaccines is expected to accelerate with 4 new partnerships between the private and public sectors announced by the US National Institute of Allergy and Infectious Diseases (NIAID) (2000) (0)
Harrison's Online Updates (2001) (0)
Behavior Increased implementation of education programs and attempts to modify behavior Use of condoms and other barrier methods Treatment and prevention of drug and alcohol abuse Clean syringes (2007) (0)
Eastern Equine Encephalitis Virus—Another Emergent Arbovirus in the United States (2020) (0)
NIH Summit on Anti-SARS-CoV-2 Antibodies for Treatment and Prevention of COVID-19—Lessons Learned and Remaining Questions (2021) (0)
Preface Harrison's Manual of Medicine (2019) (0)
Fifty years: advancing knowledge, improving health. (1999) (0)
Special Plenary Session (2004) (0)
La necesidad de una vacuna universal contra la gripe (2018) (0)
SHORT COMMUNICATION Relationship of the Genes for Chediak-Higashi Syndrome (Beige) and the T-Cell Receptor y Chain in Mouse and Man (1987) (0)
HIV-Infected Individuals and Effector Responses of B Cells in CpG Oligonucleotides Enhance Proliferative (2008) (0)
Acquired immunodeficiency syndrome (AIDS). (1985) (0)
Interleukin 2 in vitro corrects the defect in natural killer cell activity in the chediak higashi syndrome (1985) (0)
Comments on “ Cytomegalovirus ( CMV ) – Encoded UL 144 ( Truncated Tumor Necrosis Factor Receptor ) and Outcome of Congenital CMV Infection ” (2010) (0)
World AIDS Day 2003. (2003) (0)
The Human B Cell Cycle: Activation, Proliferation, and Differentiation (1985) (0)
Correction (2019) (0)
Science for the common good. (2002) (0)
Correction. (2020) (0)
Comprar Harrison’s Neurology in Clinical Medicine | Eugene Braunwald | 9780071741033 | Mcgraw-Hill Education (2010) (0)
Chapter 8 – Establishment of Human—Human and Human—Mouse B Cell Hybrids and Their Use in the Study of B Cell Activation (1983) (0)
Laudatio: in celebration of the 80th birthday of Maurice R. Hilleman, Ph.D. (2000) (0)
Vitamin and Trace Mineral Deficiency and Excess (Chapter 326) (2018) (0)
Detection Assays for HIV Proteins (2001) (0)
Harrison's Infectious Diseases; Second Edition. (2013) (0)
CDC Changes Rules for Counting Vaccinated Breakthrough Cases — Will Count Only Deaths and Hospitalizations (2022) (0)
Protection of rhesus macaques against vaginal SHIV challenges by VRC01 and an anti-α4β7 antibody (2018) (0)
Orbital Manifestations of Wegenerʼs Granulomatosis on Computer Assisted Tomography (1977) (0)
Peering into the Infectious Future Of Emerging Infectious Diseases (2016) (0)
A conversation with Tony Fauci. Interviewed by Ushma S. Neill. (2014) (0)
Human B-Cell Growth and Differentiation Factors Secreted by T-Cell Hybridomas (1985) (0)
[Gentamicin in the treatment of respiratory tract infections in infancy]. (1969) (0)
Correction (2004) (0)
Finding Ways to Improve Patients’ Cancer Immunotherapy Response (2022) (0)
Thirty Years of HIV/AIDS: A Personal Journey (2011) (0)
Chapter 19. Mechanisms of Action of Glucocorticosteroids (1978) (0)
Example : Internet in 1970 (2022) (0)
The acquired immunodeficiency syndrome (AIDS): an update. (1985) (0)
Acquired Immune Deficiency Syndrome (2017) (0)
Determination of Neutrophil Half-Life (1975) (0)
Response : HIV Quasispecies and Resampling (1996) (0)
In memoriam: Albert Z. Kapikian, MD, 1930-2014. (2015) (0)
In the News (2008) (0)
Correction (2018) (0)
and B Cell Helper Function (1984) (0)
Harrison's Online Updates (2001) (0)
PRESENTATION OF THE C. EVERETT KOOP HIV/AIDS HEALTH LEADERSHIP AWARD TO VADM C. EVERETT KOOP, MD, SCD, 13TH U.S. SURGEON GENERAL (2011) (0)
Induction of polyclonal B cell activation and differentiation by the AIDS retrovirus (HTLV-III/LAV) (1986) (0)
Cytomegalovirus-specific Cytotoxic Activities of Lymphocytes from Patients with the Acquired Immune Deficiency Syndrome (1983) (0)
Correction (2020) (0)
The following protocols describe PCR amplification and polyacrylamide gel electrophoresis conditions for subtype determination of HIV-1 envelope (env) sequences using heteroduplex mobility assay (0)
SEPARATION METHODS, SURFACE MARKERS AND CYTOTOXIC CAPABILITIES OF HUMAN EOSINOPHILS (1977) (0)
The George M. Kober lecture. Basic immunology: the path to the delineation of the immunopathogenic mechanisms of HIV infection. (1988) (0)
Response: Correlates of Protective Viruses Damaging to HIV Infection. (1996) (0)
Cell-mediated immunity-resistance to infection and so much more. (1977) (0)
Correction (2013) (0)
Faith, Science, and Trust: African American Clergy & Community Conversation on COVID-19 (2021) (0)
Leading Edge Perspective EmergingPandemicDiseases : HowWeGottoCOVID-19 (2020) (0)
Reply to Fedson (2009) (0)
Introduction to the Proceedings of the 4th World Congress on Tuberculosis (2003) (0)
Volume Information (1986) (0)
Facial Erysipelas in the Immunocompromised Host (2017) (0)
Etiology and immunopathogenesis of the acquired immunodeficiency syndrome (1986) (0)
The U.S. Presidential Election (2020) (0)
Nonspecific Interstitial Pneumonitis in Patients with (1987) (0)
LORENZO MORETTA , ANt ) (2003) (0)
Ending the Global HIV Epidemic Begins at the Individual National Level: An Update from the United States (2020) (0)
Constitutive production of a reverse transcriptase negative aids retrovirus particle (1987) (0)
Receptors Used as Coreceptors for HIV Entry Dendritic Cells Express Multiple Chemokine (1998) (0)
Nurses play critical role in care of AIDS patients. (1987) (0)
Modulation of surface ia expression on human b lymphocytes (1984) (0)
Comprar Harrison's Gastroenterology And Hepatology 3rd Ed. | A. Fauci | 9781259835841 | MCGRAW HILL (2017) (0)
LIB: State-of-the-Art, from Equipment to Researchers (2005) (0)
Book ReviewTextbook of Immunology (1979) (0)
Anthony Fauci (2008) (0)
Relationship between expression of Fc gamma receptors or Ia antigens and cytolytic activities of alloactivated human T cells. (1983) (0)
Opening Keynote Session (2008) (0)
[Clinical and electroretinographic study of a case of coloboma of the optic nerve with absence of retinal vascularization]. (1968) (0)
8:30 am OPEN SESSION: Welcome and NIH Director's Report (2014) (0)
Does Contrast Enhancement Predict Survival in Progressive Multifocal Leukoencephalopathy ? (2010) (0)
Introduction: Recent advances in the pathogenesis of human immunodeficiency virus infection (2004) (0)
Cytokines and cytokine antagonists control the replication of the human immunodeficiency virus (HIV) in vitro (1994) (0)
Lithium carbonate for recurrent fever and neutropenia (1982) (0)
Effect of hydrocortisone (OHC) on the recirculating lymphocyte pool in man (1975) (0)
Harrison's 14 (1999) (0)
Michael M. Frank: February 28, 1937–August 1, 2019 (2019) (0)
Japan to allow limited human embryonic cloning (2008) (0)
A Case Report of Wilson's Disease with Unusual Findings (2000) (0)
Contents, Vol. 51, 1976 (2004) (0)
Correction (2019) (0)
The Ohio State University Commencement Address by Anthony S. Fauci, Spring 2016 (2016) (0)
United States of America (1996) (0)
Fever of Unknown Origin-Reply (1978) (0)
Live with Dr. Fauci (2020) (0)
Correction (2019) (0)
Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes (1983) (0)
Connecting the dots on interferon responsiveness in HCV/HIV co-infection: The virus, the cytokine, the receptor and the gene (2009) (0)
PRELIMINARY RESULTS OF TRIMETREXATE (TMTX) ALONE OR IN COMBINATION WITH A SULFONAMIDE FOR THE TREATMENT OF PNEUMOCYSTIS PNEUMONIA IN AIDS PATIENTS (1987) (0)
Evolving Omicron Subvariants Are More Resistant to Antibody Therapy (2022) (0)
[The treatment of small angles of strabismus with the aid of prisms]. (1968) (0)
The rapid spread of Zika virus through the Americas and its devastating consequences for pregnant women and infants have precip (2016) (0)
Future directions in human immunobiology. (1985) (0)
[Evaluation of retinal correspondence with various tests in relation to the amount of the deviation in concomitant strabismus]. (1966) (0)
SARS-CoV-19’s actual initial cases in Wuhan, China and the impact of different interventions and imports in the pandemic. (2021) (0)
Interleukin 2 in H U M a N B Cell Function (2003) (0)
Mechanisms of corticosteroid suppression of cytotoxic responses to alloantigens. (1976) (0)
Comprar Harrison. Gastroenterología y hepatología | Anthony S. Fauci | 9786071508287 | Mcgraw-Hill Interamericana (2013) (0)
Multifactorial Nature ofHumanImmunodeficiency Virus Disease: Implications forTherapy (2016) (0)
E109 Ending the HIV/AIDS Pandemic: Research and Implementation (2013) (0)
Antibody production in man : in vitro synthesis and clinical implications : proceedings of the Catharijne Conference on Immunology held in Utrecht, Holland on March 15-18, 1978 (1979) (0)
Correction (2019) (0)
The explosive pandemic of Zika virus infection occurring throughout South America (2016) (0)
Acquired Immune Deficiency Syndrome (AIDS): Basic findings (1985) (0)
Cytotoxic Effector Cells in the Bone Marrow of Normal Humans (1976) (0)
Author index (1975) (0)
Introduction:Advances in the immunology of human immunodeficiency virus (HIV) infection (1993) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium; role of macrophages and lymphocytes as reservoirs of HIV-1 (1989) (0)
25 years of AIDS (2006) (0)
Letter from Anthony Fauci, National Institutes of Health to Harold Varmus (1985) (0)
The T4 epitope is not required for a normal replicative cycle of human immunodeficiency virus. (1987) (0)
146 α4β7: A Newly Discovered Receptor for HIV (2009) (0)
Factitious Fever and Self-Induced Infection (2020) (0)
Exogenous IL-2 Independent Antigen-Specific Human T Cells: Antigen-Specific Induction of Polyclonal B Cell Factors (1985) (0)
Immunologic Approaches to the Therapy of Auto-Immune Salivary Gland Disease (1987) (0)
Harrison Manual de Medicina Interna 18ed (2013) (0)
Libraries with HIV-1-Positive Sera Epitopes by Screening Random Peptide Selection of HIV-Specific Immunogenic (1999) (0)
NIAID, AmFAR launch huge new study of HIV infection. (1991) (0)
1122 THE AMERICAN COLLEGE OF RHEUMATOLOGY 1990 CRITERIA FOR THE CLASSIFICATION OF GIANT CELL ARTERITIS (2010) (0)
Live chat with Dr. Fauci discussing how to slow the spread of Covid (2020) (0)
Researchers Identify New Strain of HIV Derived from Gorillas (2017) (0)
Contributors (2015) (0)
Correction (2019) (0)
Correction (2020) (0)
Guiding America through a pandemic (2022) (0)
Correction (2019) (0)
SUMMARY OF WORKSHOP: HUMAN B CELL FUNCTION: RECENT ADVANCES, UNANSWERED QUESTIONS, AND FUTURE DIRECTIONS (1979) (0)
Acknowledgment to Dartmouth Medical Center (1981) (0)
E-102 Ending the HIV/AIDS pandemic: The convergence of treatment and prevention (2016) (0)
PLAQUE FORMING CELL ASSAY FOR THE MEASUREMENT OF POLYCLONAL ACTIVATION OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES. CELLULAR REQUIREMENTS AND INTERACTIONS (1977) (0)
news in brief (2002) (0)
Immunology of the acquired immunodeficiency syndrome. (1988) (0)
Harrison. Gastroenterología y hepatología (2013) (0)
News in brief (1966) (0)
Macrophage-Tropic HIV Envelope T Cells by + Primary Human CD4 Receptor 5 and Focal Adhesion Kinase in Intracellular Association of CC Chemokine Induction of Phosphorylation and (1999) (0)
C. Everett Koop (2013) (0)
Harrison. Gastroenterología y hepatología (2013) (0)
Legends of allergy and immunology: Lorenzo Moretta—Unfolding the mysteries of NK cells and much more (2022) (0)
on B Cell Costimulatory Function Deleterious Effect of HIV-1 Plasma Viremia (2003) (0)
Emerging infectious diseases. Authors'reply (2005) (0)
Harrison perensiple of internal widicin (2012) (0)
PULSE CYCLOPHOSPHAMIDE THERAPY FOR WEGENER'S GRANULOMATOSIS. AUTHOR'S REPLY (1991) (0)
From the National Institutes of Health. (1995) (0)
An interview with Anthony S. Fauci, MD. Interview by Mark Mascolini. (1996) (0)
Harrison's Online Updates (2001) (0)
FOCUS Nov-06 Evidence-Based Conundrum (2007) (0)
Correction (2006) (0)
Cytokine-induced Cell Death And Expression Of Hiv-1. Do Tumor Necrosis Factor-α (tnf-α) And Interferon-γ (ifn-γ) Selectively Kill Hiv-infected Cells? (1993) (0)
Correction (2016) (0)
Correction (2019) (0)
News in brief (1968) (0)
DISCUSSION Predicting COVID-19 Vaccine Uptake (2022) (0)
Correction (2020) (0)
Emerging Infectious Diseases—Reply (2005) (0)
Keynote Message - Dr. Anthony S. Fauci (2022) (0)
IMMUNOFLUORESCENT STUDIES IN ADULT CELIAC DISEASE TABLE (0)
Factors AssociatedWith AMR and Key Response Strategies (2016) (0)
What Will It Take to Respond to the Threat of Zika? (2016) (0)
Nonhuman Primates 7 Integrin in Various b 4 a and Regulation of Species-Specific Differences in the Expression (2015) (0)
Letter from Anthony Fauci to C. Everett Koop (1996) (0)
A renaissance for HIV vaccines? (2010) (0)
C. EVERETT KOOP, 14 OCTOBER 1916 - 25 FEBRUARY 2013. (2014) (0)
Correlates of Protective Viruses Damaging to HIV Infection (1996) (0)
Activation and immunoregulation of human B lymphocyte function: implications in normal and disease states. (1983) (0)
Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. (2004) (0)
The Effects of the AIDS Epidemic on the Safety of the Nation ' s Blood Supply (2006) (0)
The Eff iciency o f Acute Infect ion o f CD 4 + T cells Is Markedly Enhanced in the Sett ing o f Ant igen (2003) (0)
The Haskins Lectureship in Science Policy, November 15, 2002 (2003) (0)
Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected Ul cells : Inhibition of inductive effects by the interleukin 1 receptor antagonist ( cytokines / NF-icB / latency ) (2005) (0)
StimulationInduction of HIV-1 Replication by Allogeneic (1999) (0)
Brief DeBnitive Report (2003) (0)
Biographical Memoirs: Maurice R. Hilleman (2007) (0)

This paper list is powered by the following services:

Anthony Fauci's AcademicInfluence.com Rankings

Anthony Fauci's Degrees

Why Is Anthony Fauci Influential?

Anthony Fauci's Published Works

Published Papers

Other Resources About Anthony Fauci

What Schools Are Affiliated With Anthony Fauci?

Image Attributions

Anthony Fauci

Anthony Fauci's Academic­Influence.com Rankings

Anthony Fauci's Degrees

Why Is Anthony Fauci Influential?

Anthony Fauci's Published Works

Published Papers

Other Resources About Anthony Fauci

What Schools Are Affiliated With Anthony Fauci?

Image Attributions

Anthony Fauci's AcademicInfluence.com Rankings